Low-cost prosthetic limbs — the passive, mechanical design that ALIMCO, BMVSS and ALC Pune fit at scale, as distinct from the sensing, motorised prosthetics described in Section 4. Source: Afurse, Wikimedia Commons, CC BY-SA 3.0.

India's artificial-limb capacity runs through three largely separate channels that rarely get compared to each other. ALIMCO (Artificial Limbs Manufacturing Corporation of India) is a not-for-profit, Mini-Ratna Category-II Central Public Sector Enterprise under the Department of Empowerment of Persons with Disabilities (DEPwD), Ministry of Social Justice & Empowerment — it manufactures aids and appliances (not only limbs: calipers, wheelchairs, hearing aids and tricycles are all part of its catalogue) and distributes them mainly through central-government camps. ADIP (Assistance to Disabled Persons for Purchase/Fitting of Aids and Appliances) is the funding mechanism behind those camps — a Central Sector Scheme running since 1981 that pays for the aids ALIMCO and other manufacturers supply, subject to an income test. BMVSS (Bhagwan Mahaveer Viklang Sahayata Samiti), the Jaipur-based charity behind the "Jaipur Foot," is a private, donation-funded operation that fits every limb it makes free of cost, with no government income test at all.

ALIMCO's own company profile states it has supplied aids and appliances to about 4.5 million beneficiaries since inception — a figure that spans every product line, not limbs alone, and whose end date isn't specified on the page it appears on. The corporation was incorporated on 30 November 1972, though its own 2025 social-media messaging described it as "empowering Divyangjan & Senior Citizens since 1976," and separate coverage of a 2025 event called it a "53rd Foundation Day" (which points back to 1972) — a four-year discrepancy inside ALIMCO's own public communications that this piece could not resolve. It operates through 6 Auxiliary Production Centres (Bhubaneswar, Jabalpur, Bengaluru, Mohali, Ujjain, Faridabad), a 7th under construction in Tripura, 7 Regional Marketing Centres and roughly 50 after-sales service centres branded AASRA.

BMVSS states, in a brochure dated 29 April 2024, that it has provided aids to "over 2.25 million" beneficiaries — though other pages on its own website, at other dates, cite figures from "over 2 million" to "2.5 million," an inconsistency this piece is flagging rather than resolving in either direction. What BMVSS's materials agree on is that the device itself — the Jaipur Foot, a rubber-based below-knee prosthesis designed in 1968 by Ram Chandra Sharma and orthopaedic surgeon P. K. Sethi specifically to work with Indian floor-sitting postures, muddy fields and squat toilets without being removed — is given away, not sold cheaply. BMVSS's founder, Devendra Raj Mehta, received the Padma Bhushan; the organisation itself holds the Ministry of Social Justice & Empowerment's National Award for Best Institution Working in the Field of Rehabilitation of the Disabled.

ALIMCO and BMVSS figures are cumulative "since inception" totals covering different, unstated time horizons — not a like-for-like annual comparison. See sources below for the specific pages each figure was drawn from.

DEPwD revised ADIP's income-eligibility guidelines effective 26 September 2024. Under the current rules, a household earning up to ₹22,500 a month gets an aid or appliance free; a household earning ₹22,501–30,000 a month gets it at 50% of cost; above ₹30,000, the scheme does not apply. Those figures replace older, lower thresholds — roughly ₹15,000 for a free device and a ₹20,000 ceiling — that had been in circulation for years. Both thresholds rose by exactly 50%.

A Business Standard report on the Union Budget 2025-26, published 1 February 2025 — more than four months after the revision took effect — still cited the old ₹15,000/₹20,000 figures when describing ADIP's eligibility rules. That the scheme had already moved to ₹22,500/₹30,000 by then didn't make it into that coverage. It's a small, specific example of a pattern this piece kept running into while researching India's disability-aid system: the primary documents move, and the secondary reporting built on top of them doesn't always catch up. The same Budget 2025-26 allocated ₹316.7 crore to ADIP specifically, inside a total DEPwD budget of ₹1,275 crore (up 9.22% on the prior year's revised estimate).

The Artificial Limb Centre (ALC) in Pune was established on 19 May 1944 to rehabilitate Indian soldiers wounded fighting for the Allied Forces in the Second World War. It is now a 190-bed, tri-services facility of the Armed Forces Medical Services, attached to the Armed Forces Medical College, and treats serving personnel, veterans and their dependents, paramilitary forces (BSF, CRPF, Assam Rifles, ITBP), and — on payment — civilians and patients referred from Nepal, Bhutan, Afghanistan and Bangladesh. Per the centre's own account, it has treated more than 60,000 patients since inception; trauma is the most common cause of disability among them, mine-blast injury the most frequent mechanism, and below-knee amputation the most common level. ALC hosted a national continuing-education event on amputee rehabilitation, "Improving Outcomes in Amputee Rehabilitation," on 11–12 December 2025.

In August 2026, the Director General of Armed Forces Medical Services, Surgeon Vice Admiral Arti Sarin, visited ALC Pune and unveiled an in-house-developed prosthetic foot for varied-terrain mobility named the "Phoenix Foot Mk-I," alongside a new integrated "Saksham" rehabilitation clinic combining multiple therapy disciplines into one pathway. Both are reported so far only by a specialist defence-affairs outlet, not by a Press Information Bureau release this piece could locate independently — worth verifying directly with DGAFMS or ALC's public-affairs office before treating either as fully confirmed. What is independently documented, via the Indian Air Force's own coverage, is a human case at the same facility: Corporal Varun Kumar, whose right hand was amputated after he was wounded during Operation Sindoor (launched 7 May 2025), was fitted with an artificial limb at ALC and later met the Air Force Chief on a visit to the centre.

Coverage for serving and retired personnel runs through the Ex-Servicemen Contributory Health Scheme (ECHS), which covers prosthetic limbs and assistive devices with valid medical justification, cashless, through empanelled facilities at ECHS-approved rates — reimbursement for a device bought outside that network isn't guaranteed. ECHS's standard operating procedure dates to 2018 and its compendium to 2022; this piece could not locate a published, prosthetic-specific reimbursement ceiling separate from ECHS's general medical-cost rules, which is either a genuine gap in what's public or simply a detail buried in a document this piece's sourcing didn't reach.

The companies that built the modern prosthetics industry are, overwhelmingly, not Indian. Germany's Ottobock — maker of the C-Leg and other microprocessor-controlled knees — reported core revenue of €1,599.7 million for 2025, up 11.7% on 2024, and has run an Indian subsidiary out of Mumbai since 1997; it recently built a dedicated prosthetics warehousing and logistics hub in India with Celcius Logistics, covering over 2,000 SKUs across 24 clinics and 200-plus independent partners. Iceland's Össur restructured its parent company into "Embla Medical" on 8 April 2024, with Össur continuing as a product brand alongside College Park and FIOR & GENTZ; Össur's i-Limb bionic hand line came from its acquisition of Scotland's Touch Bionics — in 2016, not as part of the 2024 rebrand, a distinction some secondary summaries blur. The UK's Blatchford Group makes the Elan hydraulic microprocessor foot and the Linx system, which it describes as the only fully integrated prosthesis in which the knee and ankle communicate with each other. The US's Fillauer LLC traces its lineage to a 1914 Chattanooga pharmacy and was spun out of Cardinal Health in 1993; Hanger Inc. operates the largest US clinic network for orthotics and prosthetics, with counts across its own materials ranging from roughly 900 to over 1,000 locations depending on the snapshot date, and more than 1,800 board-certified clinicians.

The more recent wave is built around sensing and motorised control rather than passive mechanics. The UK's Open Bionics makes the Hero Arm, the first clinically approved 3D-printed bionic arm, available through more than 800 fitting locations across the US, UK, Europe, Australia and New Zealand — this piece found no evidence of an India distribution channel. The US's Mobius Bionics commercialises the LUKE Arm, which began as a DARPA-funded programme with the Department of Veterans Affairs in 2006, was FDA-cleared in May 2014, and was spun into a dedicated company in July 2016. Poland/US-based Aether Biomedical, founded 2018, makes the Zeus Bionic Hand (152 N grip force, 12 grip patterns, app-configurable) and raised $5.8 million in a 2023 funding round. The US's PSYONIC markets the Ability Hand as the world's first touch-sensing bionic hand, streaming 30 touch-sensor values over Bluetooth or USB and feeding vibration back to the wearer's residual limb. Japan's BionicM, founded by amputee engineer Xiaojun Sun out of a University of Tokyo lab (roughly 2015–2018, sources vary on the exact incorporation year), makes a powered lower-limb prosthesis, the Bio Leg, that received FDA Class II exempt device registration in 2024.

India isn't absent from this technology curve, but its footprint is small and recent. In July 2023, ALIMCO signed a technology-transfer agreement with IIT Madras and Bengaluru's Society of Biomedical Technology to produce "KADAM," an indigenous four-bar polycentric knee joint — this piece could not locate the primary IIT Madras or PIB announcement confirming the exact date, only secondary industry-roundup coverage, so treat the date as approximate pending direct verification. ALC Pune's "Phoenix Foot Mk-I," discussed above, is the military's own parallel effort, similarly under-documented in primary sources so far. Neither is a sensing or motorised device in the way Ottobock's Genium, PSYONIC's Ability Hand or BionicM's Bio Leg are; both are, as best this piece can establish, mechanical refinements of passive prosthetic design.

The policy lever that might eventually change that, India's Production-Linked Incentive (PLI) Scheme for Medical Devices, carries a total outlay of ₹3,420 crore across FY2022-23 to FY2026-27 and covers four segments, one of which is described as "all implants including implantable electronic devices." As of March 2025 the scheme had 21 approved projects manufacturing 54 device types — MRI machines, CT scanners, dialyzers, heart valves. Nothing in the scheme's own documentation that this piece reviewed specifically names externally-worn prosthetic limbs or orthotics as covered products; "implants" in medical-device policy typically means devices placed inside the body, not strapped or socketed onto it, so it would be a mistake to read the PLI scheme as already subsidising ALIMCO- or BMVSS-style prosthetic manufacturing without a clearer read of its notified product list.

There is, on top of that, no reliable public estimate of how big India's prosthetics market even is. The only reasonably specific figure this piece could find — IMARC Group's estimate of a $59.6 million Indian "prosthetics" market in 2025, growing to $88.3 million by 2034 — comes from a paywalled commercial report whose methodology this piece could not inspect; a separate, much larger IMARC figure ($2.62 billion in 2024) covers the broader "orthopedic devices" category, which includes implants and braces well beyond prosthetic limbs, and should not be quoted as if it described the same market. No government or industry-body figure specific to prosthetics was found. For a sector this policy-relevant, that is itself worth noting: nobody in the public domain can currently say, with a source anyone could check, how large India's artificial-limb market actually is.